Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2002-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.301.3.900PMID 12023517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to “Prostaglandins and cyclooxygenases in the spinal cord” [Progress in Neurobiology 64 (2001) 327–363]

  2001influential reference
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo *

  2001influential reference
• The vanilloid receptor (VR1)‐mediated effects of anandamide are potently enhanced by the cAMP‐dependent protein kinase

  2001cited by this paper
• Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.

  2001cited by this paper
• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

  2001cited by this paper
• Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen

  2001influential reference
• Novel mechanism of blocking axonal Na+ channels by three macrocyclic polyamine analogues and two spider toxins

  2001cited by this paper
• Prostaglandins and cycloxygenases in the spinal cord

  2001influential reference
• Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

  2000influential reference
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

  2000cited by this paper
• Oxidative metabolism of anandamide.

  2000influential reference
• Prostaglandin E2‐induced sensitization of bradykinin‐evoked responses in rat dorsal root ganglion neurons is mediated by cAMP‐dependent protein kinase A

  2000cited by this paper
• The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

  2000influential reference
• Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils.

  1999cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999cited by this paper
• Activation and recovery of the PGE2-mediated sensitization of the capsaicin response in rat sensory neurons.

  1997cited by this paper
• Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2*

  1997cited by this paper
• Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins.

  1995cited by this paper
• VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes

  1994cited by this paper
• Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum

  1992cited by this paper
• Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues

  1986cited by this paper

• The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms

  2024cites this paper
• Untargeted urine metabolomics and machine learning provide potential metabolic signatures in children with autism spectrum disorder

  2024cites this paper
• EP4 Receptor Conformation Sensor Suited for Ligand Screening and Imaging of Extracellular Prostaglandins

  2023influential citation
• The Effects of Endogenous Cannabinoids on the Mammalian Respiratory System: A Scoping Review of Cyclooxygenase-Dependent Pathways

  2023cites this paper
• Cannabinoid-Based Medicine: Pharmacology and Drug Interactions

  2022cites this paper
• Altered productions of prostaglandins and prostamides by human amnion in response to infectious and inflammatory stimuli identified by mutliplex mass spectrometry.

  2020cites this paper
• Endocannabinoid and Prostanoid Crosstalk in Pain.

  2019cites this paper
• Physiology of the Endocannabinoid System During Development.

  2019cites this paper
• Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues

  2018cites this paper
• The endogenous bioactive lipid prostaglandin D2‐glycerol ester reduces murine colitis via DP1 and PPARγ receptors

  2018cites this paper
• The COX-2/prostanoid signaling cascades in seizure disorders

  2018cites this paper
• The roles of prostaglandin E2, prostaglandin F2α and aldo-keto reductase 1C isoenzymes in endometriosis and breast cancer

  2017cites this paper
• Chapter 24 – Prostaglandins, Leukotrienes, and Related Compounds

  2017cites this paper
• N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.

  2017cites this paper
• Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids

  2017cites this paper
• Le cannabis thérapeutique, application à la maladie de Parkinson et essai de mise en forme galénique

  2016cites this paper
• Cannabinoids and haemostasis.

  2016cites this paper
• A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation

  2016cites this paper
• Kannabinoidy a hemostaza * Cannabinoids and haemostasis

  2016cites this paper
• SEX STEROID HORMONE INFLUENCE ON ENDOCANNABINOID SYSTEM IN THE FEMALE REPRODUCTIVE TRACT

  2016cites this paper
• The endocannabinoid anandamide and endometrial remodelling: importance of cyclooxygenase-2 metabolites

  2016cites this paper
• Regulation of inflammation by cannabinoids, the endocannabinoids 2‐arachidonoyl‐glycerol and arachidonoyl‐ethanolamide, and their metabolites

  2015cites this paper
• Application of Mass Spectrometry in Unravelling the Secrets of the Endocannabinoid System

  2015cites this paper
• Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling

  2015cites this paper
• Design and synthesis of novel prostaglandin E2 ethanolamide and glycerol ester probes for the putative prostamide receptor(s).

  2015cites this paper
• Novel tail and head group prostamide probes.

  2015cites this paper
• A Validated Molecular Docking Study of Lipid–Protein Interactions

  2015cites this paper
• Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.

  2014cites this paper
• Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

  2014cites this paper
• Identification and characterization of a major prostaglandin glycerol ester hydrolase in human cancer cells

  2014cites this paper
• COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.

  2014cites this paper
• Prostaglandins and Other Lipid Mediators eview ndogenous cannabinoids revisited : A biochemistry perspective

  2013cites this paper
• Vascular actions of oleamide in health and disease

  2013cites this paper
• Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.

  2013influential citation
• Eicosanoids as Diagnostics for Preterm Labor

  2013cites this paper
• The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects

  2013cites this paper
• Endogenous cannabinoids revisited: a biochemistry perspective.

  2013cites this paper
• Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics

  2013cites this paper
• Insulin signalling depends on the endocannabinoid system in the brain

  2013cites this paper
• The role of endocannabinoids in pregnancy.

  2013cites this paper
• Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells.

  2013cites this paper
• Functional Autoradiography as a Pharmacological Approach for Studying G Protein-Coupled Lipid Receptor Signalling

  2013cites this paper
• The role of endocannabinoids in pain modulation

  2013cites this paper
• Therapeutic implications of disorders of cell death signalling: membranes, micro‐environment, and eicosanoid and docosanoid metabolism

  2012cites this paper
• Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla

  2012cites this paper
• Design & Synthesis of Prostaglandin Ethanolamide Covalent Probes for the Investigation of Novel Physiological Activity and Discovery of a Prostaglandin Intermediate Scaffold for FAAH Inhibition

  2012cites this paper
• The Endocannabinoid 2-Arachidonoyl-Glycerol Activates Human Neutrophils: Critical Role of Its Hydrolysis and De Novo Leukotriene B4 Biosynthesis

  2011cites this paper
• Cannabinoids: potential targets for bladder dysfunction.

  2011cites this paper
• This information is current as Biosynthesis 4 and De Novo Leukotriene B Neutrophils : Critical Role of Its Hydrolysis 2-Arachidonoyl-Glycerol Activates Human The Endocannabinoid

  2011cites this paper
• Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways

  2011cites this paper
• ESTUDIO DE VARIOS FÁRMACOS ANTIGLAUCOMATOSOS SOBRE DIVERSOS ASPECTOS MORFOLÓGICOS Y FUNCIONALES DEL SEGMENTO ANTERIOR

  2011cites this paper
• The effects of cannabinoids on insulin secretion

  2011cites this paper
• Impact du système endocannabinoïdien sur la physiologie de l'obésité : effets de l'antagonisme des récepteurs CB1 sur le métabolisme glucido-lipidique de la souris obèse

  2010cites this paper
• Bimatoprost Effects on Aqueous Humor Dynamics in Monkeys

  2010cites this paper
• Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost

  2010cites this paper
• Prostaglandin Endoperoxide Synthases: Structure, Function, and Synthesis of Novel Lipid Signaling Molecules

  2010cites this paper
• Cannabinoids and Reproduction: A Lasting and Intriguing History

  2010cites this paper
• Biotin-anandamide: a new tool to visualize anandamide inside the cells

  2010cites this paper
• Lipidomic methodologies applicable to the study of endocannabinoids and related compounds: Endocannabinoidomics

  2009cites this paper
• Two different mechanisms for modulation of bronchoconstriction in guinea-pigs by cyclooxygenase metabolites.

  2009cites this paper
• The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.

  2009cites this paper
• Prostanoid receptor antagonists: development strategies and therapeutic applications

  2009cites this paper
• Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

  2009cites this paper
• Sistema endocannabinoide e inflamación intestinal

  2008cites this paper
• Vasorelaxation caused by cannabinoids: mechanisms in different vascular beds.

  2008cites this paper
• An experimental study of mediators in allergic bronchoconstriction with focus on eicosanoids

  2008cites this paper
• Prostamides (prostaglandin‐ethanolamides) and their pharmacology

  2008cites this paper
• Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

  2008cites this paper
• Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes

  2008cites this paper
• The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products.

  2008cites this paper
• Endocannabinoids: synthesis and degradation.

  2008cites this paper
• Removal of Endocannabinoids by the Body: Mechanisms and Therapeutic Possibilities

  2008cites this paper
• [Endocannabinoid system and bowel inflammation].

  2008cites this paper
• The ‘specific’ tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake

  2007cites this paper
• Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta

  2007cites this paper
• Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

  2007cites this paper
• Critical enzymes involved in endocannabinoid metabolism.

  2007cites this paper
• The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action

  2007influential citation
• The endocannabinoid system and its protective role in ischemic and cytotoxic injuries of brain neurons

  2007cites this paper
• ONO-54918-07, a stable prostacyclin analogue, mimics the effect of prostaglandin PGE1 on NG108-15 cells

  2007cites this paper
• The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.

  2007cites this paper
• Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline iris

  2007cites this paper
• Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

  2007cites this paper
• PGE2 glycerol ester, a COX‐2 oxidative metabolite of 2‐arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons

  2006influential citation
• Reflexes from the Lungs and Airways Mediator mechanisms involved in TRPV 1 and P 2 X receptor-mediated , ROS-evoked bradypneic reflex in anesthetized rats

  2006cites this paper
• The endocannabinoid system: current pharmacological research and therapeutic possibilities.

  2006cites this paper
• New insights into endocannabinoid degradation and its therapeutic potential.

  2006cites this paper
• [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].

  2006cites this paper
• Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.

  2006cites this paper
• El sistema cannabinoide en situaciones de neuroinflamación: perspectivas terapéuticas en la esclerosis múltiple

  2006cites this paper
• Lipid Signaling and Synaptic Plasticity

  2006cites this paper
• Mediator mechanisms involved in TRPV1 and P2X receptor-mediated, ROS-evoked bradypneic reflex in anesthetized rats.

  2006cites this paper
• Fatty acid amide hydrolase: a potential target for next generation therapeutics.

  2006cites this paper
• Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.

  2006cites this paper
• Non-CB1, Non-CB2 Receptors for Endocannabinoids

  2005cites this paper
• Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.

  2005cites this paper
• The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs.

  2005cites this paper
• Endocannabinoids and vanilloid TRPV1 receptors

  2005cites this paper
• Occurrence, Biosynthesis, and Metabolism of Endocannabinoids

  2005cites this paper
• Pharmacology of the Oxidative Metabolites of Endocannabinoids

  2005cites this paper